Trials / Completed
CompletedNCT00824720
Safety and Efficacy of a Glaucoma Drug Delivery System
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Vistakon Pharmaceuticals · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the ocular safety and efficacy of a glaucoma drug delivery system in open-angle glaucoma or ocular hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | High Dose Device | inserted for 14 days |
| DRUG | Low Dose Device | inserted for 14 days |
| DEVICE | Placebo Device | inserted for 14 days |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2009-04-01
- Completion
- 2009-04-01
- First posted
- 2009-01-19
- Last updated
- 2015-03-06
- Results posted
- 2010-05-14
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00824720. Inclusion in this directory is not an endorsement.